Casdin Capital, based in New York, backs life sciences and healthtech startups from Pre-Seed to Series B, typically following other investors, with notable investments like 23andMe and Adaptive Biotechnologies.
9 people on the investing team. Partners are listed first.








Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Casdin Capital reports entry at pre-seed, seed, series a, series b.
Casdin Capital has not reported a check size.
Casdin Capital mostly follows other investors.
Shaun Rodriguez, PhD, Suzanne Angell, Eileen Maysek, Eli Casdin, Jack McGuire, Noah Burhance.
No recent activity since September 2026.
Work at Casdin Capital? Claim or correct this profile.